Gene-directed enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB1954 in cells expressing bacterial nitroreductase

Gene Ther. 1998 Jan;5(1):105-12. doi: 10.1038/sj.gt.3300569.

Abstract

Clones of human colon carcinoma (WiDr), ovarian carcinoma (SK-OV-3), and Chinese hamster V79 cells expressing the nitroreductase enzyme (NR) from E. coli B were 52-, 225- and 177-fold respectively more sensitive to a 24-h incubation with the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) than the parent lines. The IC50s of non-NR-expressing bystander cells were measured in the presence of differing proportions of NR-expressing cells. The shift in IC50 was used to calculate a value for the bystander effect, termed the transmission efficiency (TE), which is the decrease in IC50 due to bystander effect as a percentage of the maximum decrease possible. The percentage of NR-expressing cells for which the TE was 50%, (the TE50) is a single datum of bystander efficacy. WiDr and V79 cell lines, had a similar TE50 of approximately 2%. SK-OV-3 gave a lower value of 0.3%. These TE50 correlate with concentrations of cytosolic NR activity, which is distinguished from endogenous DT diaphorase activity by kinetic differences. A novel method is described which enables both DNA crosslinks and drug-induced single-strand breaks to be simultaneously quantified in a sedimentation assay. Using this technique, bystander DNA damage was demonstrated in V79 cells, of approximately 50% of that in activator cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aziridines / therapeutic use*
  • DNA Damage*
  • Escherichia coli / enzymology
  • Gene Expression
  • Genetic Therapy / methods*
  • Humans
  • Neoplasms / therapy*
  • Nitroreductases / genetics*
  • Prodrugs / therapeutic use
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Aziridines
  • Prodrugs
  • tretazicar
  • Nitroreductases